The Australian Academy of Health and Medical Sciences elects the best and brightest minds in the field of medical and health sciences as Fellows.

Fellows are elected in recognition of their outstanding achievements and exceptional contributions to the sector. The Fellowship are acknowledged for their clinical, non-clinical, leadership, industry and research contributions.

About Fellowship with AAHMS

Find Fellows of the AAHMS

To find Fellows of our Academy either use the search form below or download the full list of current Fellows here.






Uehiro Chair in Practical Ethics
University of Oxford
Corresponding Fellow

Professor Savulescu trained in medicine and philosophy in Melbourne, and is now an internationally leading medical ethicist, specialising in the ethics of new biotechnologies, in particular in medicine and neuroscience. He has launched major initiatives in ethics of genomics, stem cells, bioenhancement and neuroethics. He has built interdisciplinary collaborations addressing ‘collective action problems’ such as antimicrobial resistance and vaccination, and influenced policy on current issues such as cloning, stem cell research, assisted dying, mitochondrial transfer, and abortion. He built self-sustaining bioethics research programmes in the UK and Australia, and has trained a new generation of scholars in medical ethics.

Director, Haemodialysis Services
Princess Alexandra Hospital

Professor Carmel Hawley is an Academic Clinical Nephrologist, and in recognition of her substantial involvement in kidney disease research, was recently awarded the Priscilla Kincaid-Smith Medal. However, her greatest contribution has been as the principal driver, and inaugural Chair of the Executive Operations Secretariat for the Australasian Kidney Trials Network (AKTN). The major goal of the AKTN is to conduct investigator initiated randomised controlled trials in nephrology to improve the evidence base in this discipline, and to build research skills and capabilities across the kidney care community. With a strong international profile, AKTN’s research has impacted both clinical practice and policy creation.

Director, Centre for Inflammatory Diseases
Monash University

Professor Richard Kitching is a Nephrologist physician-scientist who has made sustained and important contributions to our understanding of kidney disease. These include defining the roles of T lymphocytes and their subsets in mediating kidney injury, and the protective role of regulatory T cells in immune kidney disease. He has defined key parts of molecules that cause renal and systemic autoimmune diseases, establishing a framework for more specific therapies. His work has recently moved beyond immune kidney disease to answer a fundamental question in the biology of HLA and antigen recognition, with implications for both the understanding and future treatment of diseases.

Professor of Clinical Epidemiology
Institute for Evidence-Based Healthcare, Bond University

Professor Tammy Hoffman is Professor of Clinical Epidemiology, an NHMRC Senior Research Fellow and Lead, Centre for Evidence-Based Healthcare at Bond University. She has published 198 papers (H index 38, 6117 total citations). She has received national and international recognition in her primary discipline (Occupational Therapy, OT) and current field (Clinical Epidemiology) and substantially contributed to her professions through leadership roles in national and international societies and advisory roles to federal and state governments and international health organisations. She has led many highly-cited seminal studies, led development of globally-used resources (TIDieR statement, shared decision making online training), and co-developed OTseeker (evidence database).

Head, Embryology Laboratory
Victor Chang Cardiac Research Institute

Professor Sally Dunwoodie is an acclaimed embryologist and geneticist who has made major contributions to our mechanistic understanding of embryogenesis and the causation of congenital malformations of the skeleton and heart. Her insights into how environmental factors impact gene activity in the embryo are foundational, and in particular how gene variants interact with environmental insults including fetal hypoxia and maternal diet, to cause congenital malformation. Her discoveries have led to new diagnostics and compellingly show the way to a future where congenital malformations in tens of thousands if not millions of babies worldwide can be prevented.

Deputy Director
The Walter and Eliza Hall Institute of Medical Research

Professor Alan Cowman is an expert in the field of malaria and his work has determined how malaria parasites evade lethal effects of important antimalarial drugs. This knowledge allowed detection of drug resistant malaria parasites to understand prevalence and spread of drug resistance, important for developing public policy on antimalarial use. He developed tools to manipulate the parasite genome and constructed genetically attenuated parasites as novel avenues to develop vaccines which have progressed to human clinical trials. His work has identified new targets in the malaria parasite for development of antimalarials which are currently in development with Merck USA.

Head, Health Economics and Process Evaluation Program
The George Institute for Global Health

Professor Stephen Jan is an acknowledged authority in the field of health economics, especially as it relates to the economics of noncommunicable disease. The outcomes of his research have informed decisions around investment in health programs nationally and internationally, as well as contributed significantly to global dialogues around universal health coverage. His frequently world-first research achievements are matched by his leading discipline profile, evidenced by his exceptional level of peer funding and his highlevel appointments, including membership of the Commonwealth Government’s Primary Care Clinical Committee of the MBS Review Taskforce.

Vice President and Executive Dean
Flinders University

Professor Jonathan Craig is a Paediatric Nephrologist and Clinical Epidemiologist. He has published over 700 research articles cited >29,300 times, and his h index is 72 (Scopus). CIA on a current NHMRC Program Grant and a Centre of Research Excellence, he has supervised >30 PhD students to successful completion. His research has led to better prevention, identification, and treatment of chronic kidney disease, particularly in children and in Indigenous communities. He leads state, national and international networks conducting high quality research in adults with kidney disease, and in children, and has been instrumental in developing best-practice guidelines for chronic kidney disease in Australia and globally.

Director, Queensland Brain Institute
The University of Queensland

Professor Sah has made seminal contributions to understanding the neural circuits underlying learning and memory formation in the mammalian brain. His pioneering studies have delineated the local circuits in the amygdala, a region of the brain critical in assigning emotional salience to events, as well as the receptors engaged during amygdala-dependent learning. He has also made significant discoveries regarding properties of the ion channels that underpin action potential generation, and demonstrated how these channels contribute to the discharge properties of central neurons and synaptic transmission. These findings have led to a clearer understanding of the pathology of anxiety-related disorders.

Laboratory Head
Monash University

Professor John Bertram is internationally recognised for his outstanding research contributions in kidney developmental biology, developmental origins of kidney and cardiovascular health and disease, and quantitative imaging. He has shown that low nephron number in kidneys is linked to high blood pressure and kidney disease in animals and several human populations. These findings have contributed to initiatives to develop approaches for the non-invasive imaging and counting of glomeruli which is anticipated to improve clinical management of people with, and at risk of developing, kidney disease and hypertension. He has played significant roles in mentorship of young students and scientists.

Our Fellows sit at the heart of everything we do. They represent Australia’s leading minds in health and medical sciences, having been recognised for their clinical, non-clinical, leadership, industry and research contributions.

To be considered for election to the Academy’s Fellowship, a candidate must show exceptional professional achievement in a field related to health and/or medicine.

Fellows contribute to the projects and activities of the Academy and must be willing to be active participants.

Successful Fellowship candidates will have shown:

  • Outstanding leadership in their field.
  • Significant and ongoing involvement with issues of health care, prevention of disease, education, research, and health services policy and delivery.

Candidates for Fellowship should meet the following criteria:

  • National and International recognition for excellence in health and medical science
  • Significant, sustained and ongoing contributions to advance health and medical science in Australia (relative to opportunity)
  • Contribution to the profession through leadership and mentorship
  • Raised public understanding and promoting health and medical science in the broader community

Download criteria for Fellowship

Each year, current Fellows of the Academy are invited to nominate up to four new candidates who meet the criteria and fulfil the required expectations.

Nominations by a Fellow of two new candidates must ensure that at least one nomination is a woman. Nominations by a Fellow of four new candidates must ensure that at least two nominations are women.

How to make a nomination

Fellows wishing to nominate a candidate for Fellowship should contact the secretariat to confirm candidate eligibility and receive and instructions on how to submit the completed nomination documentation online. 

Fellows wishing to nominate a candidate for a Corresponding Fellowship should contact the secretariat for more information.

Secretariat contact details
Email: [email protected]

Phone: 07 3102 7220

Nomination guidelines for ordinary Fellowship

October 2022
Newly elected Fellows of 2022 are inducted at the Annual Meeting.

Late September 2022-November 2022
Nominations are invited from existing Fellows until the closing date of 30 November.

December 2022
Nominations allocated to Selection Committees.

January – April 2023
Referees’ reports sought.

Early May 2023
Selection Committees meet to consider nominations and provide final recommendations to the Council.

Early-to-mid-July 2023
Council meets to finalise recommendations.

Late July 2023
Full Fellowship invited to comment on recommended new fellows.

August 2023
Election results are shared with proposers and candidates (under embargo).

October 2023
Newly elected Fellows of 2023 inducted at the Annual Meeting.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.